Viking Therapeutics Inc [VKTX] stock prices are up 10.58% to $24.57 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The VKTX shares have gain 15.46% over the last week, with a monthly amount drifted -20.46%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Viking Therapeutics Inc [NASDAQ: VKTX] stock has seen the most recent analyst activity on April 08, 2025, when Goldman initiated its Neutral rating and assigned the stock a price target of $30. Previously, Scotiabank started tracking the stock with Sector Outperform rating on February 13, 2025, and set its price target to $102. On February 07, 2025, Citigroup initiated with a Neutral rating and assigned a price target of $38 on the stock. Piper Sandler started tracking the stock assigning a Overweight rating. B. Riley Securities initiated its recommendation with a Buy and recommended $109 as its price target on November 22, 2024. H.C. Wainwright reiterated a Buy rating for this stock on November 04, 2024, and upped its price target to $102. In a note dated September 11, 2024, JP Morgan initiated an Overweight rating and provided a target price of $80 on this stock.
The stock price of Viking Therapeutics Inc [VKTX] has been fluctuating between $18.92 and $81.86 over the past year. Currently, Wall Street analysts expect the stock to reach $98 within the next 12 months. Viking Therapeutics Inc [NASDAQ: VKTX] shares were valued at $24.57 at the most recent close of the market. An investor can expect a potential return of 298.86% based on the average VKTX price forecast.
Analyzing the VKTX fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.12, Equity is -0.12 and Total Capital is -0.17. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 23.06 points at the first support level, and at 21.56 for the second support level. However, for the 1st resistance point, the stock is sitting at 26.58, and for the 2nd resistance point, it is at 28.60.
Ratios To Look Out For
It’s worth pointing out that Viking Therapeutics Inc [NASDAQ:VKTX]’s Current Ratio is 33.09. Also, the Quick Ratio is 33.09, while the Cash Ratio stands at 0.97.
Transactions by insiders
Recent insider trading involved Rouan Sarah Kathryn, Director, that happened on Mar 31 ’25 when 1240.0 shares were purchased. President & CEO, Lian Brian completed a deal on Jan 06 ’25 to sell 0.19 million shares. Meanwhile, Chief Operating Officer Mancini Marianna sold 54215.0 shares on Jan 06 ’25.
